UK PR pitch could portend US acquisitions for AstraZeneca

Share this article:
AstraZeneca is reviewing its UK financial PR business amid media speculation on a possible acquisitions run in the US, reports our sister publication, PRWeek UK.

The company is hearing pitches from multiple City of London communications agencies including incumbent Brunswick, FD, Finsbury and Tulchan Communications, all of which specialize in financial PR.

The business is worth a sum in the low six figures in fees, though project work around mergers and acquisitions could pad that out considerably, reported PRWeek UK. The review comes amid speculation that the company could buy Shire and beef up its US operations through acquisitions. 
Share this article:

Email Newsletters

More in News

FDA kind of OKs Lilly/BI's Lantus look-alike

FDA kind of OKs Lilly/BI's Lantus look-alike

Sanofi's patent lawsuit triggered the tentative approval of the Lilly-BI Lantus competitor.

GSK relaunches COPD.com

GSK relaunches COPD.com

The refresh launched soon after the company encouraged investors to take a long view of GSK as the firm posted weak respiratory numbers.

Six things for pharma marketers to know: Tuesday, August 19

Six things for pharma marketers to know: Tuesday, ...

Lilly/BI receives tentative approval for insulin biosimilar; Ebola death rate hits new high; LaMattina sounds off on Pfizer's oncology efforts; art therapy becoming the norm in hospitals.